Veralox Therapeutics agrees Nudge Therapeutics acquisition
Johnson & Johnson granted Priority Review for nipocalimab in gMG
Hemogenyx Pharmaceuticals raises GBP340,000 for AML clinical trials
Hemogenyx Pharmaceuticals announces first clinical site for HG-CT-1 Phase I trial
Zura Bio announces global Phase 2 TibuSURE trial for systemic sclerosis treatment
Breckenridge Pharmaceutical launches FDA approved methadone injection
Hansa Biopharma reports positive Phase 2 imlifidase results
Nona Biosciences signs research collaboration and licence agreement with Candid Therapeutics
Gilead Sciences secures positive CHMP opinion for seladelpar in PBC treatment
Full Circles Therapeutics advances non-viral gene editing innovation
Hansa Biopharma completes enrolment in anti-GBM disease trial
Transposon Therapeutics acquires portfolio of novel nucleoside analogues from PrimeFour Therapeutics
Adicet Bio doses first patient in Phase 1 trial of ADI-001 for lupus nephritis
Pulmatrix announces merger with Cullgen to advance targeted protein degradation